CBD, oxidative stress and inflammation: understanding the connection

What is oxidative stress?

Cells use oxygen to produce energy and also generate reactive oxygen species (ROS), including superoxide and hydrogen peroxide. Small amounts of ROS participate in normal signaling and immune defense. Oxidative stress refers to an imbalance in which potentially damaging oxidative activity exceeds the capacity of protective systems.

The body has its own antioxidant defenses

Cells use glutathione, superoxide dismutase (SOD), catalase, glutathione peroxidase and many other protective processes. One regulator is Nrf2. Under baseline conditions its activity is constrained by Keap1; particular stresses allow Nrf2-dependent genes, including HO-1 and NQO1, to become more active.

Why CBD is discussed alongside Nrf2 and NF-κB

The original examines experiments in which CBD altered oxidative signaling and pathways involving Nrf2 and NF-κB. NF-κB participates in inflammatory gene expression and cytokine responses. Changes in these signals in a cell culture or animal model are meaningful mechanistic observations, but cannot prove a therapeutic benefit in people.

Inflammation and ROS can amplify each other

Macrophages and neutrophils deliberately generate ROS to attack microorganisms. During prolonged inflammation, excessive ROS can also damage host tissue. Tissue injury can then promote further immune recruitment and cytokine production. Conversely, redox signals may influence NF-κB and mediators such as TNF-α, IL-1β and IL-6.

The NLRP3 inflammasome

NLRP3 is part of an intracellular inflammatory signaling complex associated with the maturation of IL-1β and IL-18 and, in some settings, pyroptotic cell death. Researchers have examined whether CBD can modulate NLRP3 activity in experimental models. These experiments do not establish CBD as a treatment for a specific inflammatory disease.

Antioxidant and pro-oxidant effects may coexist

CBD has been associated with antioxidant effects in some conditions but with increases in oxidative activity in others. Normal cells and malignant cells can differ in metabolism and stress tolerance. A concentration that reduces an inflammatory response in one experimental system may not have the same effects in another. The concept of a universally protective “natural antioxidant” is therefore misleading.

Why this matters in oncology

Radiotherapy and some chemotherapy treatments partly work by causing cellular damage, including oxidative injury. It is unsafe to assume that adding an antioxidant alongside these regimens will always help; certain combinations could theoretically interfere with intended effects. Conversely, experimental pro-oxidant effects against a tumor cell do not establish cancer-treatment efficacy. Decisions about supplements or cannabinoid products during cancer care need oncology oversight.

The brain and the gut are additional research areas

Neuroinflammatory conditions such as Parkinson’s, Alzheimer’s and multiple sclerosis involve complex immune and oxidative processes. Gut epithelial barriers also face microbiome, inflammatory and oxidative challenges. The original discusses CBD research into Nrf2, NF-κB and NLRP3 in these contexts, but does not report clinical proof of neurological protection or cure of bowel disease.

Dose and context are central

More CBD does not necessarily mean greater benefit or improved safety. Redox signaling can be beneficial at one level and harmful at another, and products vary in concentration and interactions. Understanding the relevant cell type, disease, dose, timing and accompanying treatment is essential.

Key conclusions

CBD sits at an interesting intersection of oxidative and inflammatory pathways. It can influence biological markers in experimental settings, which makes it valuable to study. Those effects should not be marketed as proof of a broad anti-inflammatory, neuroprotective or anticancer medicine. Appropriate diagnosis and established treatment must come first.

Read original Hebrew article ↗

Scientific sources cited by the Hebrew original

1. The dual roles of natural cannabidiol in combating oxidative stress and inflammation. 2026.
   Find this source ↗
2. The molecular activity of cannabidiol in regulation of Nrf2 and NF-κB under oxidative stress.
   Find this source ↗
3. Cannabidiol as an immune modulator: A comprehensive review. 2025.
   Find this source ↗
4. Unraveling the Mechanisms of Cannabidiol's Pharmacological Actions. 2024.
   Find this source ↗